Devyser Diagnostics (DVYSR.ST) Stock Price

Devyser Diagnostics Price

OMX·CLOSED
50.80
​
Market closed

Over the last 7 years Devyser Diagnostics grew revenue by 26.6% annually, reaching 250.50 M SEK. For Devyser Diagnostics, the net margin of -3.4% is up versus -22.2% a few years ago. The consensus 12-month price target for Devyser Diagnostics is 168.30 SEK, about 231.3% above where the stock trades today. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.

Devyser Diagnostics stock price

Access this data via the Eulerpool API

Devyser Diagnostics business model & stock analysis

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm and currently employs 96 full-time employees. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

Frequently asked questions about Devyser Diagnostics

Analysts currently set an average price target of 168.30 SEK for the Devyser Diagnostics stock (median: 168.30 SEK), implying +231.3 % versus the latest price. The consensus is based on 11 analyst ratings.

11 analysts currently rate the Devyser Diagnostics stock: 10 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Devyser Diagnostics to generate revenue of 246.00 M SEK and earnings per share of 0.72 SEK.

Converted at the current exchange rate, the Devyser Diagnostics share trades at 4.54 EUR (50.80 SEK).

The Devyser Diagnostics share (DVYSR.ST) is listed on 3 stock exchanges, including: Frankfurt (OL0.F), München (OL0.MU), Stockholm (DVYSR.ST).

The expected revenue of Devyser Diagnostics is 246.00 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Devyser Diagnostics is 11.99 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Devyser Diagnostics is currently 70.77. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Devyser Diagnostics stock.

The price-to-sales ratio (P/S) of Devyser Diagnostics is currently 3.45. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Devyser Diagnostics stock.

The Eulerpool Quality Score for Devyser Diagnostics is 3/10.

The ISIN of Devyser Diagnostics is SE0016588867. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Devyser Diagnostics is A3C811. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Devyser Diagnostics is DVYSR.ST. The ticker symbol is used to trade Devyser Diagnostics shares on the stock exchange.

Fair ValueTerminal
47.75 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
2.61 M SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website devyser.com
Country
Sweden
Currency
SEK
Initial public offering
Dec 10, 2021
ISIN
SE0016588867
Cusip
W2533X146
Market capitalization
845.82 M SEKSmall Cap
52-Week Range
PEG
-1.48
P/E ratio
P/Ee 2026
70.56
P/Ee 2027
26.67
P/Ee 2028
14.85
P/S
P/Se
3.45
EV/EBIT
73.84
P/B Ratio
2.39
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-2.28 %
Last updated Oct 12, 2026, 2:17 PM

Devyser Diagnostics Peer Group

Devyser Diagnostics Ticker

FRANKFURT · OL0.FMUNICH · OL0.MUSTOCKHOLM · DVYSR.ST

Devyser Diagnostics FIGI

DVYSR:SF · BBG013X97TG8DVYSRSEK:XS · BBG013XC1757DVYSRSEK:X2 · BBG013XC1766DVYSRSEK:XH · BBG013XC1784DVYSRSEK:XF · BBG013XC17B0DVYSRSEK:XE · BBG013XC17D8DVYSRSEK:XJ · BBG013XC17F6DVYSRSEK:XL · BBG013XC17G5DVYSRSEK:XG · BBG013XC17H4DVYSRSEK:XO · BBG013XC17K0DVYSRSEK:XA · BBG013XC17Q4DVYSRSEK:E1 · BBG013XC17S2